Orser Capital Management’s Juno Therapeutics, Inc. JUNO Stock Holding History

Orser Capital Management’s Portfolio JUNO Stock Details JUNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-34,240	Closed	-$1.58M	–	117
2017 Q4	$1.58M	Buy	+34,240	New	+$1.71M	1.41%	30

Other funds holding JUNO

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM

Orser Capital Management's JUNO Position: Q1 2018 in Review

Orser Capital Management sold out of Juno Therapeutics, Inc. (JUNO) in Q1 2018, closing a stake of 34,240 shares — an estimated $1.58M sold.

Orser Capital Management first reported a position in JUNO in Q4 2017 and held it in 1 quarter. The position peaked at $1.58M in Q4 2017. 2 funds tracked by Wall St. Rank hold JUNO as of Q1 2018.

Orser Capital Management reported no remaining Juno Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
Orser Capital Management sold 34,240 Juno Therapeutics, Inc. shares in Q1 2018, an estimated $1.58M.
Orser Capital Management first reported a position in Juno Therapeutics, Inc. in Q4 2017 and held it in 1 quarter.
Orser Capital Management's Juno Therapeutics, Inc. position peaked at $1.58M in Q4 2017.
2 funds tracked by Wall St. Rank held Juno Therapeutics, Inc. as of Q1 2018.

Based on Orser Capital Management's 13F filing for Q1 2018, filed 14 Nov 2019.